US3366975A - Compound prosthesis - Google Patents
Compound prosthesis Download PDFInfo
- Publication number
- US3366975A US3366975A US461326A US46132665A US3366975A US 3366975 A US3366975 A US 3366975A US 461326 A US461326 A US 461326A US 46132665 A US46132665 A US 46132665A US 3366975 A US3366975 A US 3366975A
- Authority
- US
- United States
- Prior art keywords
- core
- prosthesis
- tissue
- pores
- implant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title description 20
- 239000011162 core material Substances 0.000 description 56
- 210000001519 tissue Anatomy 0.000 description 46
- 239000000463 material Substances 0.000 description 33
- 239000012528 membrane Substances 0.000 description 30
- 239000007943 implant Substances 0.000 description 24
- 239000011148 porous material Substances 0.000 description 24
- 230000004888 barrier function Effects 0.000 description 23
- 210000001124 body fluid Anatomy 0.000 description 17
- 239000010839 body fluid Substances 0.000 description 17
- 230000001413 cellular effect Effects 0.000 description 10
- 239000004033 plastic Substances 0.000 description 9
- 229920003023 plastic Polymers 0.000 description 9
- 230000008859 change Effects 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- 239000012530 fluid Substances 0.000 description 6
- 210000000481 breast Anatomy 0.000 description 5
- 230000007794 irritation Effects 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920005573 silicon-containing polymer Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002984 plastic foam Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/21—Silicone
Definitions
- a compound prosthesis for implanting in the human body has a core of a plastic foam, surrounded by a membrane impervious to uids and in turn covered by a porous layer to which human tissue can adhere.
- the core enables the device to retain a given shape, yet can approximate human tissue in density and rigidity to restore the body to its initial sham and appearance.
- This invention relates generally to prostheses and, particularly, to an improved compound prosthesis to be implanted within the human body, particularly in the female breast, although the invention is not necessarily limited thereto.
- prosthetic implants it becomes necessary to remove the mammary glands or substantial portions of diseased body tissue in and around the glands, thus leaving voids which may be filled by prosthetic implants.
- Such implants provide physical support for the surrounding body tissue and organs and, in the case of voids near the skin, preserve the outward appearance of the body.
- cancerous, precancerous, or damaged tissue it is often possible to insert the prosthesis to be implanted through the same surgical incision used for removing the tissue.
- prosthetic implants are those of preserving the natural softness and resiliency of the replaced body tissue and of retaining the implant in position in the body.
- the prosthesis employed preferably is soft and resilient in order to duplicate as nearly as possible the natural characteristics of the body tissue being replaced or built up.
- the use of prostheses having soft and resilient characteristics matching those of the replaced body tissues is particularly important in such cases as the female breast. In such cases, the desirability of retaining the implant iirmly in place is also obvious, both from the standpoint of appearance and also the comfort of the patient.
- inert foamtype plastic sponge materials Materials of this type are porous so that they absorb blood and other body iluids and become invaded by blood vessels and living body tissue. The result is that the sponge implant and the surrounding body tissue eventually become so interwoven as to be irmly united. This enables the implant to become anchored firmly to the chest Wall and also to the covering skin, thus becoming substantially a part of the body in the same manner as the replaced tissues.
- Implants of a compound or composite construction may include a body of a liquid or liuid substance. Implants ot this character are often heavy and subject to an undesirable change in shape because of the ability of the lluid material to flow within the implant and accumulate at a low portion thereof. This change in shape is distressing and embarrassing to the wearer and is obviously undesirable.
- Some types of compound prostheses have elements which are more or less discrete, being separable when in use. As a consequence, these prostheses are subject to the accumulation of fluid from the body in an interior void which can form between discrete elements of the prosthesis. In other cases, the possibility arises of extreme irritation of the body tissue after it has penetrated the prosthesis to a position where movement occurs between the discrete elements of the prosthesis that creates an irritation.
- prostheses are not completely covered with a cellular layer which can become invaded by living tissue. Instead such a prosthesis has more or less of its external surface provided by an impervious material. Body fluid can, and often does, accumulate between the living tissue and such an impervious surface, causing distortion and, in severe cases, breakdown of tissue at the location of the wound.
- a further object of the invention is to provide a compound prosthesis of the character described which has the qualities of softness and resiliency to the desired degree to resemble the tissue replaced, yet which is stable in shape and size so that it does not change size or shape with a change in position of the patient and also retains essentially the original size and shape over a long period of time.
- a unitary compound prosthesis for implanting under the skin which comprises a resilient core of open-cell, foam-type plastic material having numerous pores extending throughout the core so that the core provides a light-Weight, resilient structuralskeleton; a barrier membrane surrounding and bonded to the core, said menibrane being substantially impervious to body cellular tissue in order to exclude said tissue from the core', and a covering external layer which is also a resilient, foam-type plastic having numerous pores throughout the external layer whereby it is pervious to and can become invaded by body cellular tissue to a limited depth, perhaps l to 2 millimeters.
- the cells of the core are filled with a resilient gel which is soft and yielding and thereby does not impair the resilient character of the core material but which is held in place by the structural network of the sponge material of the core.
- rl ⁇ his construction has a very low permeability to body fluids or cellular tissue and has a maximum potential of retaining its original size and shape.
- the barrier membrane may be entirely impervious to cellular tissue and body fiuids.
- the cells'of the core may be left unfilled, becoming eventually filled with fluids from the body.
- the cells of the core are preferably smaller than in the form previously mentioned.
- the barrier membrane is made of a material which is itself an impervious barrier to body fluids but which is preferably provided with a plurality of small openings through which fluids may pass to accumulate in the Core, such openings being so few in number and small in size that tissue is substantially excluded from the core.
- FIG. 1 is a perspective view of a prosthesis shaped to replace a female breast, constructed in accordance with the present invention
- FIG. 2 is a vertical median section through the prosthesis of FIG. 1;
- FIG. 3 is a greatly enlarged fragmentary view of the core with the pores inltrated with gel.
- FIG. 4 is an enlarged fragmentary section and elevation of a variational form of the invention.
- a surgical prosthesis P for implanting under the skin of a human being constructed according to the present invention comprises three principal parts, core itl, barrier membrane 11, and the external layer or covering 12.
- the shape of the prosthesis illustrated is solely for purposes of illustration and is not limitative upon the invention, since this prosthesis is one which is suitable for replacing substantially an entire breast, while others will differ in size and shape according to the specific requirements of the particular patient.
- the materials are materials which are not rejected by the human body.
- the materials that are most satisfactory are those which are nonabsorbent and are, therefore, not subject to absorption of germs or bacteria but which, on the other hand, can be easily rendered sterile in an autoclave without damage to the prosthesis.
- Exemplary materials for the prosthesis will be mentioned, but are not necessarily limitative upon the invention.
- Corey l() is preferably made of an open-cell polyurethane characterized by a degree of softness and resiliency closely comparable to the human tissue which it replaces.
- the foam-type plastic sponge material is sufficiently strong to retain its original shape after implanting.
- a silicone sponge can be used but is not as strong as the polyurethane.
- Open-cell polyurethane provides a porous structure in which there are numerous pores extending throughout the entire body of the core. These pores are preferably larger than the minimum size and may be characterized as large pores. In one embodiment of the invention, these pores lila are filled with a gel, as shown in FIG. 3 at 14, which is also soft and resilient so that it does not impair the overall resilient character of the composite core.
- the foam-type sponge material provides a struc ⁇ tural framework or stroma which gives physical strength and shape to the core and supports the small bodies of gel which fill the pores in the core.
- a core of this type in which the gel fills the pores is characterized by being substantially impervious to body fluids and body tissues.
- the open-cell sponge is, usually, more rigid than the gel; and as a consequence, the firmness of the final product can be controlled within the desirable range by proper selection of pore size.
- a structure having large porcs is preferred as it gives the desired firmness while the gel filling the pores is softer or more yielding and so adds bulk without adding too much rigidity. Reduction in pore size increases the firmness of the sponge.
- This membrane is preferably made of a material which is impervious to fluids and also impervious to body tissues. Typical of such materials are various silicone polymers of medical grade.
- the silicone material may be applied to the core in any suitable manner, as by wrapping the core in a sheet of silicone material which is then bonded to the core over substantially the entire area of the membrane and core in mutual contact, by the application of heat and light pressure. It is preferred to use a silicone of paste-like consistency that can be applied to the core over its entire exterior surface.
- the silicone is mixed with a room temperature vulcanizing agent, eliminating the need of heating in a mold to cure the silicone.
- the layer is preferably kept thin, typically about 1.0 millimeter or less and preferably about 0.5 millimeter. This thickness is adequate to be impervious but not thick enough to add undesired rigidity to the final product. Apart from the undesired rigidity, the membrane can be made thicker if de sired. Generally speaking, any material that provides a barrier impervious to body cellular tissue is satisfactory for the membrane, provided it is flexible and elastic to substantially the same degree as the core and is medically acceptable.
- a continuous external layer or covering 12 Surrounding the barrier membrane is a continuous external layer or covering 12 which is also an open-cell, foam-type sponge material.
- a suitable material for this purpose is a foamed polyether or a polyurethane which can be bonded to the core so that there is substantial adherence between the outer layer and the barrier member over their entire areas in mutual Contact.
- the covering layer is preferably one which is characterized by small pores.
- the porosity of the outer layer is designed to permit it to become invaded by body cellular tissue, thereby causing the implant to adhere firmly to the wall of the chest and also to the covering skin and tissues. Thus the implant eventually becomes united with the surrounding tissues over substantially its entire exterior surface.
- the external layer 12 has been found advantageous to make the external layer 12 substantially uniform in thickness and relatively thin, it preferably being of the order of l or 2 millimeters in thickness, not more than about 2 millimeters being preferred.
- the advantage of this relatively thin external layer is that while it is thick enough to become thoroughly invaded by human tissue for anchoring the implant to the surrounding body, yet the total mass of the outer layer is also sufficiently small that the shrinkage of the fibroblast as the tissue ages and hardens has little effect in shrinking or changing the shape of the implant.
- the small volume of the implant which can become invaded by tissue keeps the shrinkage Within acceptable limits.
- the outer covering is preferably applied to the prosthesis in the form of a sheet of material which is shaped over the membrane-covered core and is bonded to the outer surface of the barrier membrane. Joints in the sheet material forming the outer layer are formed with abutting edges of the layer in contact so that they are bonded together and the outer layer is substantially continuous, although minor discontinuities in the outer layer do not interfere with satisfactory functioning of the prosthesis.
- a convenient way of making the prosthesis is to apply the outer layer while the barrier membrane l1 is still plastic.
- the membrane as it cures then bonds to both the core and to the outer layer.
- the prosthesis constituting the present invention is not limited to any particular method of manufacture, it is preferred to cover the porous sponge material of the core with the barrier membrane before filling the pores of the sponge material with the gel.
- the core can then be impregna-ted with material in liquid form, using a hollow needle for this purpose. Air in the pores will be displaced by this liquid which forms the gel and can be withdrawn through another hollow needle.
- a suitable liquid material for this purpose is one of the elastomeric silicone polymers which has been compounded to produce the desired degree of elasticity in the gel produced.
- One such material is that prepared by Dow Corning as a solution with a 35036O centistoke viscosity.
- This silicone compound is mixed just prior to injection with a curing or vulcanizing agent which operates at room temperatures and is currently designated as a room temperature vulcanizing solution.
- a curing or vulcanizing agent which operates at room temperatures and is currently designated as a room temperature vulcanizing solution.
- the pores of the core are completely filled with the gel of a suitable degree of stiffness.
- the composite nature of the core is such that it remains soft and elastic, but the framework of the sponge-type material holds the gel against flowing or shifting its position with a change in position of the wearer, thus avoiding any change in shape of the completed prosthesis.
- the invention may be embodied in a prosthesis which is constructed as described except that the gel is omitted and the original pores of the foam-type material are left filled with air at the time of implantirig.
- the barrier membrane 11 is perforated in any suitable manner, as with a needle, to provide it with a plurality of small openings 15 which render the membrane pervious to a desired degree to body fluids.
- the body fluids then flow through these openings into the core, displacing the air therefrom and eventually filling the core with body fluids.
- the barrier membrane is preferably the same thickness as mentioned, typically about 0.5 millimeter, and the thin external layer 12 is fastened to the membrane in the same manner and has all the same characteristics already mentioned.
- the outer layer being pervious to body fluids, these body fluids can reach the small perforations in the membrane and pass through these perforations. While such perforations might allow body cellular tissue limited access to the core, yet they are so small and few in number that the amount of tissue which can reach and invade the core is negligible.
- Both forms of the invention described provide a structure which is advantageous because all the elements of the prosthesis are rmly bonded together to form an integrated structure. This eliminates all voids Within the layers of the prosthesis which could either develop into spaces in which fluid from the body can accumulate or which could become invaded by tissue. When there is the capability of relative movement between portions of the prosthesis into which body tissue has entered, the movement causes irritation of the tissue that results both in the accumulation of fluid and in discomfort to the wearer Both conditions are avoided by the present invention since either one may eventually lead to the necessity for removal of a prosthesis.
- a unitary compound surgical prosthesis for implanting under the skin of a human being comprising:
- a barrier membrane surrounding and bonded to the core, said membrane being substantially impervious to body cellular tissue to exclude said tissue from the core;
- a unitary compound surgical prosthesis as in claim 5 in which the barrier membrane is made of a non-porous material and has a plurality of minute perforations which pass body fluids.
- a unitary compound surgical prosthesis for implanting under the skin of a human being comprising:
- a resilient core of opencell, foam-type plastic material having numerous pores extending throughout the core, the pores of the core containing an elastic gel excluding body fluids from the core;
- a barrier membrane not more than about 0.5 millimeter thick surrounding and bonded to the core, said mem- 7 8 brane being substantially impervious to body cellular References Cited tissue to exclude said tissue from the core; UNITED STATES PATENTS and an external layer not more than about 2 millimeters thick of a resilient, foam-type plastic having numer- 2,842,775 7/1958 Pangman 3-36 ous pores throughout the external layer whereby the 5 1g;
- external layer is relatively pervious to body uids and body cellular structure, said external layer surrounding and being bonded t0 RICHARD A GAUDET Primary Examiner' the barrier membrane. R. FRINKS, Assistant Examiner.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Description
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US461326A US3366975A (en) | 1965-06-04 | 1965-06-04 | Compound prosthesis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US461326A US3366975A (en) | 1965-06-04 | 1965-06-04 | Compound prosthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
US3366975A true US3366975A (en) | 1968-02-06 |
Family
ID=23832123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US461326A Expired - Lifetime US3366975A (en) | 1965-06-04 | 1965-06-04 | Compound prosthesis |
Country Status (1)
Country | Link |
---|---|
US (1) | US3366975A (en) |
Cited By (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3548420A (en) * | 1967-03-06 | 1970-12-22 | Stryker Corp | Cushion structure |
US3594796A (en) * | 1968-07-18 | 1971-07-20 | Int Standard Electric Corp | Distance measuring |
US3665520A (en) * | 1970-10-07 | 1972-05-30 | Medical Eng Corp | Surgically implantable breast prosthesis |
US3683424A (en) * | 1970-01-30 | 1972-08-15 | William J Pangman | Surgically implantable compound breast prosthesis |
FR2448892A1 (en) * | 1979-02-19 | 1980-09-12 | Polar Plastik Hb | CHEST PROSTHESIS |
EP0030838A1 (en) * | 1979-12-17 | 1981-06-24 | Dow Corning Corporation | Silicone gel-filled silicone rubber article possessing reduced surface-bleed |
US4298998A (en) * | 1980-12-08 | 1981-11-10 | Naficy Sadeque S | Breast prosthesis with biologically absorbable outer container |
US4380569A (en) * | 1981-08-03 | 1983-04-19 | Spenco Medical Corporation | Lightweight preformed stable gel structures and method of forming |
US4455691A (en) * | 1979-10-03 | 1984-06-26 | Minnesota Mining And Manufacturing Company | Silicone gel filled prosthesis |
US4472226A (en) * | 1979-10-03 | 1984-09-18 | Minnesota Mining And Manufacturing Company | Silicone gel filled prosthesis |
EP0125400A1 (en) * | 1983-04-18 | 1984-11-21 | EBERL, Tertulin | Breast prosthesis |
WO1985000744A1 (en) * | 1983-08-17 | 1985-02-28 | Reinmueller Johannes | Synthetic material implant |
US4531244A (en) * | 1983-07-14 | 1985-07-30 | Hamas Robert S | Mammary prosthesis with multiple flow spaces |
WO1986001997A1 (en) * | 1984-09-26 | 1986-04-10 | Tertulin Eberl | Breast prosthesis |
US4740208A (en) * | 1980-11-21 | 1988-04-26 | Cavon Joseph F | Cast gel implantable prosthesis |
US4773909A (en) * | 1981-10-06 | 1988-09-27 | Memorial Hospital For Cancer And Allied Diseases | Multi-lumen high profile mammary implant |
EP0293256A1 (en) * | 1987-05-27 | 1988-11-30 | Mentor Corporation | Method of producing textured surface prosthesis implants |
US5007929A (en) * | 1986-11-04 | 1991-04-16 | Medical Products Development, Inc. | Open-cell, silicone-elastomer medical implant |
US5035716A (en) * | 1987-12-07 | 1991-07-30 | Downey Ernest L | Replacement disc |
AU617667B2 (en) * | 1986-11-04 | 1991-12-05 | Allergan, Inc. | Open-cell, silicone-elastomer medical implant and method for making |
US5092348A (en) * | 1989-01-17 | 1992-03-03 | Mcghan Medical Corporation | Textured tissue expander |
US5116370A (en) * | 1991-03-22 | 1992-05-26 | Foglietti Mark A | Breast prosthesis with female and male adapter snaps |
US5141581A (en) * | 1972-10-08 | 1992-08-25 | Markham Harold A | Implants with a cover which resists formation of firm spherical encapsulation |
US5147404A (en) * | 1987-12-07 | 1992-09-15 | Downey Ernest L | Vertebra prosthesis |
US5158571A (en) * | 1990-03-09 | 1992-10-27 | Picha George J | Tissue expander and method for expanding tissue |
US5271736A (en) * | 1991-05-13 | 1993-12-21 | Applied Medical Research | Collagen disruptive morphology for implants |
US5296069A (en) * | 1991-12-27 | 1994-03-22 | Silimed-Silicone E. Instrumental Medico Cirurgico E. Hosiptalar Ltda. | Process for manufacturing implants having coated surfaces |
US5376117A (en) * | 1991-10-25 | 1994-12-27 | Corvita Corporation | Breast prostheses |
US5383929A (en) * | 1987-12-22 | 1995-01-24 | Ledergerber; Walter J. | Implantable prosthetic device |
US5496370A (en) * | 1992-03-13 | 1996-03-05 | Robert S. Hamas | Gel-like prosthetic device |
US5525275A (en) * | 1993-07-27 | 1996-06-11 | Pmt Corporation | Method of manufacture of enhanced surface implant |
US5658330A (en) * | 1993-12-23 | 1997-08-19 | Mcghan Medical Corp. | Molded silicone foam implant and method for making |
US5674285A (en) * | 1986-11-04 | 1997-10-07 | Medical Products Development, Inc. | Mammary implant having shell with unitary rough-textured outer layer |
US5824081A (en) * | 1996-09-13 | 1998-10-20 | Lipomatrix Incorporated | Hydraulic foam tissue implant |
US5935164A (en) * | 1997-02-25 | 1999-08-10 | Pmt Corporaton | Laminated prosthesis and method of manufacture |
US5961552A (en) * | 1997-08-02 | 1999-10-05 | Pmt Corporation | Internally configured prosthesis |
US5964803A (en) * | 1993-07-27 | 1999-10-12 | Pmt Corporation | Enhanced surface implant and method of manufacture |
US6146419A (en) * | 1999-05-13 | 2000-11-14 | Board Of Trustees Of The University | Method for forming a hollow prosthesis |
US6228116B1 (en) * | 1987-12-22 | 2001-05-08 | Walter J. Ledergerber | Tissue expander |
US6245960B1 (en) | 1999-05-13 | 2001-06-12 | Board Of Trustees Of The University Of Arkansas | Inherent healing accelerator |
US6315796B1 (en) | 1999-05-13 | 2001-11-13 | Board Of Trustees Of The University Of Arkansas | Flexible seamless memory tissue expanding implant |
US6419704B1 (en) | 1999-10-08 | 2002-07-16 | Bret Ferree | Artificial intervertebral disc replacement methods and apparatus |
US20020128718A1 (en) * | 1999-08-13 | 2002-09-12 | Ferree Bret A. | Method of providing cells and other biologic materials for transplantation |
US20020128630A1 (en) * | 1999-08-13 | 2002-09-12 | Ferree Bret A. | Method and apparatus for providing nutrition to intervertebral disc tissue |
US6454804B1 (en) | 1999-10-08 | 2002-09-24 | Bret A. Ferree | Engineered tissue annulus fibrosis augmentation methods and apparatus |
US20020151981A1 (en) * | 1999-10-14 | 2002-10-17 | Ferree Bret A. | Transplantation of engineered meniscus tissue to the intervertebral disc |
US20020156533A1 (en) * | 1999-10-08 | 2002-10-24 | Ferree Bret A. | Natural and synthetic supplements to engineered annulus and disc tissues |
US20020156532A1 (en) * | 1999-10-08 | 2002-10-24 | Ferree Bret A. | Supplementing engineered annulus tissues with autograft or allograft tendons |
US20020165542A1 (en) * | 1999-10-08 | 2002-11-07 | Ferree Bret A. | Annulus fibrosis augmentation methods and apparatus |
US20030004574A1 (en) * | 1999-10-08 | 2003-01-02 | Ferree Bret A. | Disc and annulus augmentation using biologic tissue |
US20030026788A1 (en) * | 1999-10-08 | 2003-02-06 | Ferree Bret A. | Use of extracellular matrix tissue to preserve cultured cell phenotype |
US6520989B1 (en) | 2000-01-18 | 2003-02-18 | Board Of Trustees Of The University Of Arkansas | Extreme volume flexible integrity prosthesis |
US20030074076A1 (en) * | 1999-10-08 | 2003-04-17 | Ferree Bret A. | Artificial intervertebral disc replacements with endplates |
US6605116B2 (en) | 2001-04-03 | 2003-08-12 | Mentor Corporation | Reinforced radius mammary prostheses and soft tissue expanders |
US20030191536A1 (en) * | 1999-10-08 | 2003-10-09 | Ferree Bret A. | Artificial intervertebral disc replacements incorporating reinforced wall sections |
US20040093092A1 (en) * | 1999-10-08 | 2004-05-13 | Ferree Bret A. | Rotator cuff repair using engineered tissues |
US20040172019A1 (en) * | 1999-10-08 | 2004-09-02 | Ferree Bret A. | Reinforcers for artificial disc replacement methods and apparatus |
US20040186573A1 (en) * | 1999-10-08 | 2004-09-23 | Ferree Bret A. | Annulus fibrosis augmentation methods and apparatus |
US20040230310A1 (en) * | 1999-08-13 | 2004-11-18 | Ferree Bret A. | Use of morphogenic proteins to treat human disc disease |
US20040260396A1 (en) * | 1999-10-08 | 2004-12-23 | Ferree Bret A. | Artificial disc and joint replacements with modular cushioning components |
US20060058891A1 (en) * | 2004-09-16 | 2006-03-16 | Lesh Michael D | Transformable tissue bulking device |
US20060161253A1 (en) * | 2004-09-16 | 2006-07-20 | Michael Lesh | Tissue augmentation device |
US20080215149A1 (en) * | 2006-09-30 | 2008-09-04 | Eun Hyun Bae | Lightweight Silicone Implant and Manufacturing Method Thereof |
US20090118829A1 (en) * | 2007-11-05 | 2009-05-07 | Allergan, Inc. | Soft prosthesis shell texturing method |
US20090198329A1 (en) * | 2008-02-01 | 2009-08-06 | Kesten Randy J | Breast implant with internal flow dampening |
US20090216323A1 (en) * | 2008-01-29 | 2009-08-27 | Ledergerber Walter J | Modulating buttress saline mammary prosthesis |
US20090255618A1 (en) * | 2008-04-11 | 2009-10-15 | American Breast Care | Breast Prosthesis for Patients with Edema |
US20100042212A1 (en) * | 2008-08-13 | 2010-02-18 | Allergan, Inc. | Soft Filled Prosthesis Shell With Discrete Fixation Surfaces |
US20100042211A1 (en) * | 2008-08-13 | 2010-02-18 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US20100076113A1 (en) * | 2008-09-19 | 2010-03-25 | Mentor Corporation | Coating with antimicrobial agents |
US20100114312A1 (en) * | 2007-01-03 | 2010-05-06 | Implite Ltd | Human implantable tissue expander |
US20100198350A1 (en) * | 2008-09-19 | 2010-08-05 | Mentor Worldwide Llc | Coating with antimicrobial agents |
US20100292790A1 (en) * | 2009-05-13 | 2010-11-18 | Allergan, Inc. | Implants and methods for manufacturing same |
US20110046729A1 (en) * | 2009-08-18 | 2011-02-24 | Allergan, Inc. | Reinforced Prosthetic Implant With Flexible Shell |
US20110093069A1 (en) * | 2009-10-16 | 2011-04-21 | Allergan, Inc. | Implants and methdos for manufacturing same |
WO2011062329A1 (en) | 2009-11-19 | 2011-05-26 | Yu Won-Seok | Artificial breast implant having a surface formed into a silicon open cell foam layer, and method for manufacturing same |
US20110184531A1 (en) * | 2010-01-28 | 2011-07-28 | Allergan, Inc. | Open celled foams, implants including them and processes for making same |
US20110196488A1 (en) * | 2010-02-03 | 2011-08-11 | Allergan, Inc. | Degradation resistant implantable materials and methods |
US20110208302A1 (en) * | 2008-10-28 | 2011-08-25 | Implite Ltd. | Reconstructive breast prostheses |
US20110245921A1 (en) * | 2009-09-23 | 2011-10-06 | Amoena Medizin-Orthpaedie-Technik GmbH | Breast Prosthesis |
CN103040543A (en) * | 2011-10-14 | 2013-04-17 | 波里泰克健康和美学股份有限公司 | Process for the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process |
US8546458B2 (en) | 2010-12-07 | 2013-10-01 | Allergan, Inc. | Process for texturing materials |
ITPD20120155A1 (en) * | 2012-05-15 | 2013-11-16 | Idea Medical Devices Srl | BREAST PROSTHESIS |
US8679279B2 (en) | 2010-11-16 | 2014-03-25 | Allergan, Inc. | Methods for creating foam-like texture |
US8679570B2 (en) | 2010-04-27 | 2014-03-25 | Allergan, Inc. | Foam-like materials and methods for producing same |
US8685296B2 (en) | 2010-05-11 | 2014-04-01 | Allergan, Inc. | Porogen compositions, method of making and uses |
WO2014118773A1 (en) * | 2013-01-30 | 2014-08-07 | Implite Ltd. | Human implantable tissue expanders |
US8801782B2 (en) | 2011-12-15 | 2014-08-12 | Allergan, Inc. | Surgical methods for breast reconstruction or augmentation |
US8877822B2 (en) | 2010-09-28 | 2014-11-04 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US8889751B2 (en) | 2010-09-28 | 2014-11-18 | Allergan, Inc. | Porous materials, methods of making and uses |
US9044897B2 (en) | 2010-09-28 | 2015-06-02 | Allergan, Inc. | Porous materials, methods of making and uses |
US20150150675A1 (en) * | 2011-03-07 | 2015-06-04 | Establishment Labs S.A. | Implant with a visual indicator of a barrier layer |
US9072821B2 (en) | 2010-02-05 | 2015-07-07 | Allergan, Inc. | Biocompatible structures and compositions |
US9138308B2 (en) | 2010-02-03 | 2015-09-22 | Apollo Endosurgery, Inc. | Mucosal tissue adhesion via textured surface |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
US9205577B2 (en) | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9278158B2 (en) | 2002-07-29 | 2016-03-08 | Peter Forsell | Multi-material incontinence treatment construction device |
US20160095696A1 (en) * | 2014-10-06 | 2016-04-07 | Mark A. Anton | Gore-tex covered breast implants to minimize capsular reaction and infection while reducing palpability |
US9539086B2 (en) | 2014-05-16 | 2017-01-10 | Allergan, Inc. | Soft filled prosthesis shell with variable texture |
US9688006B2 (en) | 2012-12-13 | 2017-06-27 | Allergan, Inc. | Device and method for making a variable surface breast implant |
US9848972B2 (en) | 2008-08-13 | 2017-12-26 | Allergan, Inc. | Dual plane breast implant |
WO2018067433A1 (en) * | 2016-10-03 | 2018-04-12 | Lifecell Corporation | Breast treatment device |
IT201700002146A1 (en) * | 2017-01-11 | 2018-07-11 | Solidago Ag | INTERNAL BREAST IMPLANTS IN POLYMERIC MATERIAL EXPANDED FOR RECONSTRUCTIVE SURGERY |
US10092392B2 (en) | 2014-05-16 | 2018-10-09 | Allergan, Inc. | Textured breast implant and methods of making same |
US20200100892A1 (en) * | 2018-10-02 | 2020-04-02 | Tepha, Inc. | Medical devices to limit movement of breast implants |
US11202853B2 (en) | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US20230065905A1 (en) * | 2021-08-27 | 2023-03-02 | Cinmar, Llc | Enhancers for use with garments |
US11672648B2 (en) | 2018-07-25 | 2023-06-13 | Establishment Labs S.A. | Implants with symmetric shape |
US11766321B2 (en) | 2019-11-25 | 2023-09-26 | Tepha, Inc. | Breast implant wraps to limit movement of breast implants and related methods |
US11833027B2 (en) | 2018-02-09 | 2023-12-05 | Tepha, Inc. | Full contour breast implant |
USD1027375S1 (en) | 2021-08-27 | 2024-05-21 | Cinmar, Llc | Breast tissue enhancer |
SE2230442A1 (en) * | 2022-12-23 | 2024-06-24 | Fascia Innovation Sweden Ab | A human breast implant |
USD1040347S1 (en) | 2018-07-03 | 2024-08-27 | Tepha, Inc. | Three dimensional mastopexy implant |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2842775A (en) * | 1954-02-23 | 1958-07-15 | William J Pangman | Compound prosthesis device |
US3189921A (en) * | 1962-04-11 | 1965-06-22 | William J Pangman | Compound prosthesis |
US3293663A (en) * | 1963-08-12 | 1966-12-27 | Dow Corning | Surgically implantable human breast prosthesis |
-
1965
- 1965-06-04 US US461326A patent/US3366975A/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2842775A (en) * | 1954-02-23 | 1958-07-15 | William J Pangman | Compound prosthesis device |
US3189921A (en) * | 1962-04-11 | 1965-06-22 | William J Pangman | Compound prosthesis |
US3293663A (en) * | 1963-08-12 | 1966-12-27 | Dow Corning | Surgically implantable human breast prosthesis |
Cited By (183)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3548420A (en) * | 1967-03-06 | 1970-12-22 | Stryker Corp | Cushion structure |
US3594796A (en) * | 1968-07-18 | 1971-07-20 | Int Standard Electric Corp | Distance measuring |
US3683424A (en) * | 1970-01-30 | 1972-08-15 | William J Pangman | Surgically implantable compound breast prosthesis |
US3665520A (en) * | 1970-10-07 | 1972-05-30 | Medical Eng Corp | Surgically implantable breast prosthesis |
US5141581A (en) * | 1972-10-08 | 1992-08-25 | Markham Harold A | Implants with a cover which resists formation of firm spherical encapsulation |
US4507810A (en) * | 1979-02-19 | 1985-04-02 | Polar-Plastik Hb | Implantable breast prostheses |
FR2448892A1 (en) * | 1979-02-19 | 1980-09-12 | Polar Plastik Hb | CHEST PROSTHESIS |
US4455691A (en) * | 1979-10-03 | 1984-06-26 | Minnesota Mining And Manufacturing Company | Silicone gel filled prosthesis |
US4472226A (en) * | 1979-10-03 | 1984-09-18 | Minnesota Mining And Manufacturing Company | Silicone gel filled prosthesis |
EP0030838A1 (en) * | 1979-12-17 | 1981-06-24 | Dow Corning Corporation | Silicone gel-filled silicone rubber article possessing reduced surface-bleed |
WO1981001650A1 (en) * | 1979-12-17 | 1981-06-25 | Dow Corning | Silicone gel-filled silicone rubber article possessing reduced surface-bleed |
US4740208A (en) * | 1980-11-21 | 1988-04-26 | Cavon Joseph F | Cast gel implantable prosthesis |
US4298998A (en) * | 1980-12-08 | 1981-11-10 | Naficy Sadeque S | Breast prosthesis with biologically absorbable outer container |
US4380569A (en) * | 1981-08-03 | 1983-04-19 | Spenco Medical Corporation | Lightweight preformed stable gel structures and method of forming |
US4773909A (en) * | 1981-10-06 | 1988-09-27 | Memorial Hospital For Cancer And Allied Diseases | Multi-lumen high profile mammary implant |
EP0125400A1 (en) * | 1983-04-18 | 1984-11-21 | EBERL, Tertulin | Breast prosthesis |
US4531244A (en) * | 1983-07-14 | 1985-07-30 | Hamas Robert S | Mammary prosthesis with multiple flow spaces |
WO1985000744A1 (en) * | 1983-08-17 | 1985-02-28 | Reinmueller Johannes | Synthetic material implant |
JPS60502237A (en) * | 1983-08-17 | 1985-12-26 | ラインミユラ−,ヨハネス | plastic embeds |
US4713073A (en) * | 1983-08-17 | 1987-12-15 | Reinmueller Johannes | Plastic implant |
WO1986001997A1 (en) * | 1984-09-26 | 1986-04-10 | Tertulin Eberl | Breast prosthesis |
US5007929A (en) * | 1986-11-04 | 1991-04-16 | Medical Products Development, Inc. | Open-cell, silicone-elastomer medical implant |
AU617667B2 (en) * | 1986-11-04 | 1991-12-05 | Allergan, Inc. | Open-cell, silicone-elastomer medical implant and method for making |
US5674285A (en) * | 1986-11-04 | 1997-10-07 | Medical Products Development, Inc. | Mammary implant having shell with unitary rough-textured outer layer |
EP0293256A1 (en) * | 1987-05-27 | 1988-11-30 | Mentor Corporation | Method of producing textured surface prosthesis implants |
US5035716A (en) * | 1987-12-07 | 1991-07-30 | Downey Ernest L | Replacement disc |
US5147404A (en) * | 1987-12-07 | 1992-09-15 | Downey Ernest L | Vertebra prosthesis |
US20010010024A1 (en) * | 1987-12-22 | 2001-07-26 | Ledergerber Walter J. | Tissue expander |
US6921418B2 (en) | 1987-12-22 | 2005-07-26 | Walter J. Ledergerber | Dual-sided, texturized biocompatible structure |
US5383929A (en) * | 1987-12-22 | 1995-01-24 | Ledergerber; Walter J. | Implantable prosthetic device |
US6228116B1 (en) * | 1987-12-22 | 2001-05-08 | Walter J. Ledergerber | Tissue expander |
US5092348A (en) * | 1989-01-17 | 1992-03-03 | Mcghan Medical Corporation | Textured tissue expander |
US5158571A (en) * | 1990-03-09 | 1992-10-27 | Picha George J | Tissue expander and method for expanding tissue |
US5116370A (en) * | 1991-03-22 | 1992-05-26 | Foglietti Mark A | Breast prosthesis with female and male adapter snaps |
US5706807A (en) * | 1991-05-13 | 1998-01-13 | Applied Medical Research | Sensor device covered with foam membrane |
US5271736A (en) * | 1991-05-13 | 1993-12-21 | Applied Medical Research | Collagen disruptive morphology for implants |
US5798065A (en) * | 1991-05-13 | 1998-08-25 | George J. Picha | Collagen disruptive surface morphology for implants |
US5564439A (en) * | 1991-05-13 | 1996-10-15 | George J. Picha | Infusion device for soft tissue |
US5376117A (en) * | 1991-10-25 | 1994-12-27 | Corvita Corporation | Breast prostheses |
US5296069A (en) * | 1991-12-27 | 1994-03-22 | Silimed-Silicone E. Instrumental Medico Cirurgico E. Hosiptalar Ltda. | Process for manufacturing implants having coated surfaces |
US5496370A (en) * | 1992-03-13 | 1996-03-05 | Robert S. Hamas | Gel-like prosthetic device |
US5525275A (en) * | 1993-07-27 | 1996-06-11 | Pmt Corporation | Method of manufacture of enhanced surface implant |
US5964803A (en) * | 1993-07-27 | 1999-10-12 | Pmt Corporation | Enhanced surface implant and method of manufacture |
US5658330A (en) * | 1993-12-23 | 1997-08-19 | Mcghan Medical Corp. | Molded silicone foam implant and method for making |
US5824081A (en) * | 1996-09-13 | 1998-10-20 | Lipomatrix Incorporated | Hydraulic foam tissue implant |
US5935164A (en) * | 1997-02-25 | 1999-08-10 | Pmt Corporaton | Laminated prosthesis and method of manufacture |
US5961552A (en) * | 1997-08-02 | 1999-10-05 | Pmt Corporation | Internally configured prosthesis |
US6245960B1 (en) | 1999-05-13 | 2001-06-12 | Board Of Trustees Of The University Of Arkansas | Inherent healing accelerator |
US6283998B1 (en) | 1999-05-13 | 2001-09-04 | Board Of Trustees Of The University Of Arkansas | Alloplastic vertebral disk replacement |
US6315796B1 (en) | 1999-05-13 | 2001-11-13 | Board Of Trustees Of The University Of Arkansas | Flexible seamless memory tissue expanding implant |
US6146419A (en) * | 1999-05-13 | 2000-11-14 | Board Of Trustees Of The University | Method for forming a hollow prosthesis |
US7435260B2 (en) | 1999-08-13 | 2008-10-14 | Ferree Bret A | Use of morphogenetic proteins to treat human disc disease |
US20020128718A1 (en) * | 1999-08-13 | 2002-09-12 | Ferree Bret A. | Method of providing cells and other biologic materials for transplantation |
US20020128630A1 (en) * | 1999-08-13 | 2002-09-12 | Ferree Bret A. | Method and apparatus for providing nutrition to intervertebral disc tissue |
US20040230310A1 (en) * | 1999-08-13 | 2004-11-18 | Ferree Bret A. | Use of morphogenic proteins to treat human disc disease |
US6793677B2 (en) | 1999-08-13 | 2004-09-21 | Bret A. Ferree | Method of providing cells and other biologic materials for transplantation |
US20030074076A1 (en) * | 1999-10-08 | 2003-04-17 | Ferree Bret A. | Artificial intervertebral disc replacements with endplates |
US20020156533A1 (en) * | 1999-10-08 | 2002-10-24 | Ferree Bret A. | Natural and synthetic supplements to engineered annulus and disc tissues |
US20030004574A1 (en) * | 1999-10-08 | 2003-01-02 | Ferree Bret A. | Disc and annulus augmentation using biologic tissue |
US20030026788A1 (en) * | 1999-10-08 | 2003-02-06 | Ferree Bret A. | Use of extracellular matrix tissue to preserve cultured cell phenotype |
US7201774B2 (en) | 1999-10-08 | 2007-04-10 | Ferree Bret A | Artificial intervertebral disc replacements incorporating reinforced wall sections |
US20020156532A1 (en) * | 1999-10-08 | 2002-10-24 | Ferree Bret A. | Supplementing engineered annulus tissues with autograft or allograft tendons |
US7201776B2 (en) | 1999-10-08 | 2007-04-10 | Ferree Bret A | Artificial intervertebral disc replacements with endplates |
US20030191536A1 (en) * | 1999-10-08 | 2003-10-09 | Ferree Bret A. | Artificial intervertebral disc replacements incorporating reinforced wall sections |
US20060235535A1 (en) * | 1999-10-08 | 2006-10-19 | Ferree Bret A | Artificial disc and joint replacements with modular cushioning components |
US6648920B2 (en) | 1999-10-08 | 2003-11-18 | Bret A. Ferree | Natural and synthetic supplements to engineered annulus and disc tissues |
US20040093092A1 (en) * | 1999-10-08 | 2004-05-13 | Ferree Bret A. | Rotator cuff repair using engineered tissues |
US6755863B2 (en) | 1999-10-08 | 2004-06-29 | Bret A. Ferree | Rotator cuff repair using engineered tissues |
US20040172019A1 (en) * | 1999-10-08 | 2004-09-02 | Ferree Bret A. | Reinforcers for artificial disc replacement methods and apparatus |
US6419704B1 (en) | 1999-10-08 | 2002-07-16 | Bret Ferree | Artificial intervertebral disc replacement methods and apparatus |
US20040186573A1 (en) * | 1999-10-08 | 2004-09-23 | Ferree Bret A. | Annulus fibrosis augmentation methods and apparatus |
US7060100B2 (en) | 1999-10-08 | 2006-06-13 | Ferree Bret A | Artificial disc and joint replacements with modular cushioning components |
US20040260396A1 (en) * | 1999-10-08 | 2004-12-23 | Ferree Bret A. | Artificial disc and joint replacements with modular cushioning components |
US6454804B1 (en) | 1999-10-08 | 2002-09-24 | Bret A. Ferree | Engineered tissue annulus fibrosis augmentation methods and apparatus |
US6969404B2 (en) | 1999-10-08 | 2005-11-29 | Ferree Bret A | Annulus fibrosis augmentation methods and apparatus |
US20020165542A1 (en) * | 1999-10-08 | 2002-11-07 | Ferree Bret A. | Annulus fibrosis augmentation methods and apparatus |
US20020151981A1 (en) * | 1999-10-14 | 2002-10-17 | Ferree Bret A. | Transplantation of engineered meniscus tissue to the intervertebral disc |
US6648919B2 (en) | 1999-10-14 | 2003-11-18 | Bret A. Ferree | Transplantation of engineered meniscus tissue to the intervertebral disc |
US6520989B1 (en) | 2000-01-18 | 2003-02-18 | Board Of Trustees Of The University Of Arkansas | Extreme volume flexible integrity prosthesis |
US6605116B2 (en) | 2001-04-03 | 2003-08-12 | Mentor Corporation | Reinforced radius mammary prostheses and soft tissue expanders |
US9278158B2 (en) | 2002-07-29 | 2016-03-08 | Peter Forsell | Multi-material incontinence treatment construction device |
US20060058891A1 (en) * | 2004-09-16 | 2006-03-16 | Lesh Michael D | Transformable tissue bulking device |
US20060161253A1 (en) * | 2004-09-16 | 2006-07-20 | Michael Lesh | Tissue augmentation device |
US7641688B2 (en) | 2004-09-16 | 2010-01-05 | Evera Medical, Inc. | Tissue augmentation device |
US20080215149A1 (en) * | 2006-09-30 | 2008-09-04 | Eun Hyun Bae | Lightweight Silicone Implant and Manufacturing Method Thereof |
US8545557B2 (en) * | 2007-01-03 | 2013-10-01 | Implite Ltd | Human implantable tissue expander |
US20100114312A1 (en) * | 2007-01-03 | 2010-05-06 | Implite Ltd | Human implantable tissue expander |
US20090118829A1 (en) * | 2007-11-05 | 2009-05-07 | Allergan, Inc. | Soft prosthesis shell texturing method |
US20110117267A1 (en) * | 2007-11-05 | 2011-05-19 | Allergan, Inc. | Soft Prosthesis Shell Texturing Method |
US9138310B2 (en) | 2007-11-05 | 2015-09-22 | Allergan, Inc. | Soft prosthesis shell texturing method |
US8313527B2 (en) | 2007-11-05 | 2012-11-20 | Allergan, Inc. | Soft prosthesis shell texturing method |
US20090216323A1 (en) * | 2008-01-29 | 2009-08-27 | Ledergerber Walter J | Modulating buttress saline mammary prosthesis |
US8202316B2 (en) | 2008-01-29 | 2012-06-19 | Ledergerber Walter J | Modulating buttress saline mammary prosthesis |
US9333070B2 (en) | 2008-02-01 | 2016-05-10 | Evera Medical, Inc. | Breast implant with internal flow dampening |
US20090198329A1 (en) * | 2008-02-01 | 2009-08-06 | Kesten Randy J | Breast implant with internal flow dampening |
US7753954B2 (en) * | 2008-04-11 | 2010-07-13 | American Breast Care LP | Breast prosthesis for patients with edema |
US20090255618A1 (en) * | 2008-04-11 | 2009-10-15 | American Breast Care | Breast Prosthesis for Patients with Edema |
US20100042211A1 (en) * | 2008-08-13 | 2010-02-18 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US9393106B2 (en) | 2008-08-13 | 2016-07-19 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US9848972B2 (en) | 2008-08-13 | 2017-12-26 | Allergan, Inc. | Dual plane breast implant |
US9138311B2 (en) | 2008-08-13 | 2015-09-22 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US9918829B2 (en) | 2008-08-13 | 2018-03-20 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US8506627B2 (en) | 2008-08-13 | 2013-08-13 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US20100042212A1 (en) * | 2008-08-13 | 2010-02-18 | Allergan, Inc. | Soft Filled Prosthesis Shell With Discrete Fixation Surfaces |
US10675144B2 (en) | 2008-08-13 | 2020-06-09 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US10765501B2 (en) | 2008-08-13 | 2020-09-08 | Allergan, Inc. | Dual plane breast implant |
US8419793B2 (en) * | 2008-09-19 | 2013-04-16 | Mentor Worldwide Llc | Coating with antimicrobial agents |
US8420153B2 (en) * | 2008-09-19 | 2013-04-16 | Mentor Worldwide Llc | Coating with antimicrobial agents |
US20100076113A1 (en) * | 2008-09-19 | 2010-03-25 | Mentor Corporation | Coating with antimicrobial agents |
US20100198350A1 (en) * | 2008-09-19 | 2010-08-05 | Mentor Worldwide Llc | Coating with antimicrobial agents |
US9370414B2 (en) | 2008-10-28 | 2016-06-21 | Implite Ltd. | Reconstructive breast prostheses |
US20110208302A1 (en) * | 2008-10-28 | 2011-08-25 | Implite Ltd. | Reconstructive breast prostheses |
US20100292790A1 (en) * | 2009-05-13 | 2010-11-18 | Allergan, Inc. | Implants and methods for manufacturing same |
US9486308B2 (en) | 2009-08-18 | 2016-11-08 | Allergan, Inc. | Method of making a reinforced prosthetic implant with flexible shell |
US10251746B2 (en) | 2009-08-18 | 2019-04-09 | Allergan, Inc. | Method of making reinforcing prosthetic implant with flexible shell |
US20110046729A1 (en) * | 2009-08-18 | 2011-02-24 | Allergan, Inc. | Reinforced Prosthetic Implant With Flexible Shell |
US8409280B2 (en) * | 2009-09-23 | 2013-04-02 | Amoena Medizin-Orthopaedie-Technik Gmbh | Breast prosthesis |
US20110245921A1 (en) * | 2009-09-23 | 2011-10-06 | Amoena Medizin-Orthpaedie-Technik GmbH | Breast Prosthesis |
US8951596B2 (en) | 2009-10-16 | 2015-02-10 | Allergan, Inc. | Implants and methods for manufacturing same |
US20110093069A1 (en) * | 2009-10-16 | 2011-04-21 | Allergan, Inc. | Implants and methdos for manufacturing same |
WO2011062329A1 (en) | 2009-11-19 | 2011-05-26 | Yu Won-Seok | Artificial breast implant having a surface formed into a silicon open cell foam layer, and method for manufacturing same |
US10085831B2 (en) * | 2009-11-19 | 2018-10-02 | Won Seok Yu | Artificial breast implant provided on the surface thereof with silicone open cell foam layer, and method for producing the same |
US20110184531A1 (en) * | 2010-01-28 | 2011-07-28 | Allergan, Inc. | Open celled foams, implants including them and processes for making same |
US8487012B2 (en) | 2010-01-28 | 2013-07-16 | Allergan, Inc. | Open celled foams, implants including them and processes for making same |
US9138308B2 (en) | 2010-02-03 | 2015-09-22 | Apollo Endosurgery, Inc. | Mucosal tissue adhesion via textured surface |
US20110196488A1 (en) * | 2010-02-03 | 2011-08-11 | Allergan, Inc. | Degradation resistant implantable materials and methods |
US9072821B2 (en) | 2010-02-05 | 2015-07-07 | Allergan, Inc. | Biocompatible structures and compositions |
US10624997B2 (en) | 2010-02-05 | 2020-04-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
US10391199B2 (en) | 2010-02-05 | 2019-08-27 | Allergan, Inc. | Porous materials, methods of making and uses |
US9205577B2 (en) | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US8679570B2 (en) | 2010-04-27 | 2014-03-25 | Allergan, Inc. | Foam-like materials and methods for producing same |
US8685296B2 (en) | 2010-05-11 | 2014-04-01 | Allergan, Inc. | Porogen compositions, method of making and uses |
US11202853B2 (en) | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9593224B2 (en) | 2010-09-28 | 2017-03-14 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US8877822B2 (en) | 2010-09-28 | 2014-11-04 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9044897B2 (en) | 2010-09-28 | 2015-06-02 | Allergan, Inc. | Porous materials, methods of making and uses |
US8889751B2 (en) | 2010-09-28 | 2014-11-18 | Allergan, Inc. | Porous materials, methods of making and uses |
US9522502B2 (en) | 2010-09-28 | 2016-12-20 | Allergan, Inc. | Porous materials, methods of making and uses |
US8679279B2 (en) | 2010-11-16 | 2014-03-25 | Allergan, Inc. | Methods for creating foam-like texture |
US9155613B2 (en) | 2010-11-16 | 2015-10-13 | Allergan, Inc. | Methods for creating foam-like texture |
US8546458B2 (en) | 2010-12-07 | 2013-10-01 | Allergan, Inc. | Process for texturing materials |
US20150150675A1 (en) * | 2011-03-07 | 2015-06-04 | Establishment Labs S.A. | Implant with a visual indicator of a barrier layer |
US10111744B2 (en) * | 2011-03-07 | 2018-10-30 | Establishment Labs S.A. | Method of making a prosthesis device |
US11607306B2 (en) | 2011-03-07 | 2023-03-21 | Establishment Labs S.A. | Implant with a visual indicator of a barrier layer |
CN103040543A (en) * | 2011-10-14 | 2013-04-17 | 波里泰克健康和美学股份有限公司 | Process for the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process |
US20130096676A1 (en) * | 2011-10-14 | 2013-04-18 | Polytech Health & Aesthetics Gmbh | Process for the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process |
CN103040543B (en) * | 2011-10-14 | 2017-11-21 | 波里泰克健康和美学股份有限公司 | The implant and intermediate products for manufacturing the method for implant or the intermediate products of the implant and being obtained by this method |
US10307945B2 (en) * | 2011-10-14 | 2019-06-04 | Polytech Health & Aesthetics Gmbh | Process or the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process |
US8801782B2 (en) | 2011-12-15 | 2014-08-12 | Allergan, Inc. | Surgical methods for breast reconstruction or augmentation |
ITPD20120155A1 (en) * | 2012-05-15 | 2013-11-16 | Idea Medical Devices Srl | BREAST PROSTHESIS |
US10864661B2 (en) | 2012-12-13 | 2020-12-15 | Allergan, Inc. | Device and method for making a variable surface breast implant |
US9688006B2 (en) | 2012-12-13 | 2017-06-27 | Allergan, Inc. | Device and method for making a variable surface breast implant |
US9713524B2 (en) | 2013-01-30 | 2017-07-25 | Implite Ltd. | Human implantable tissue expanders |
WO2014118773A1 (en) * | 2013-01-30 | 2014-08-07 | Implite Ltd. | Human implantable tissue expanders |
CN105142572A (en) * | 2013-01-30 | 2015-12-09 | 因普利特有限公司 | Human implantable tissue expanders |
JP2016504955A (en) * | 2013-01-30 | 2016-02-18 | インプライト リミテッド. | Tissue dilator that can be implanted in humans |
CN105142572B (en) * | 2013-01-30 | 2018-05-11 | 因普利特有限公司 | The implantable tissue expander of the mankind |
US9808338B2 (en) | 2014-05-16 | 2017-11-07 | Allergan, Inc. | Soft filled prosthesis shell with variable texture |
US10092392B2 (en) | 2014-05-16 | 2018-10-09 | Allergan, Inc. | Textured breast implant and methods of making same |
US9539086B2 (en) | 2014-05-16 | 2017-01-10 | Allergan, Inc. | Soft filled prosthesis shell with variable texture |
US10350055B2 (en) | 2014-05-16 | 2019-07-16 | Allergan, Inc. | Textured breast implant and methods of making same |
US20230277298A1 (en) * | 2014-10-06 | 2023-09-07 | Mark A. Anton | Gore-tex covered breast implants to minimize capsular reaction and infection while reducing palpability |
US20190038396A1 (en) * | 2014-10-06 | 2019-02-07 | Mark A. Anton | Gore-tex covered breast implants to minimize capsular reaction and infection while reducing palpability |
US9901439B2 (en) * | 2014-10-06 | 2018-02-27 | Mark A. Anton | Gore-Tex covered breast implants to minimize capsular reaction and infection while reducing palpability |
US20210169637A1 (en) * | 2014-10-06 | 2021-06-10 | Mark A. Anton | Gore-tex covered breast implants to minimize capsular reaction and infection while reducing palpability |
US20160095696A1 (en) * | 2014-10-06 | 2016-04-07 | Mark A. Anton | Gore-tex covered breast implants to minimize capsular reaction and infection while reducing palpability |
WO2018067433A1 (en) * | 2016-10-03 | 2018-04-12 | Lifecell Corporation | Breast treatment device |
CN109789010A (en) * | 2016-10-03 | 2019-05-21 | 生命细胞公司 | Breast treatment device |
RU2743959C2 (en) * | 2016-10-03 | 2021-03-01 | Лайфселл Корпорейшн | Device for breast correction |
IT201700002146A1 (en) * | 2017-01-11 | 2018-07-11 | Solidago Ag | INTERNAL BREAST IMPLANTS IN POLYMERIC MATERIAL EXPANDED FOR RECONSTRUCTIVE SURGERY |
EP3348234A1 (en) * | 2017-01-11 | 2018-07-18 | Solidago AG | Internal mammary prosthesis made of polymer foam material for reconstructive surgery |
US11833027B2 (en) | 2018-02-09 | 2023-12-05 | Tepha, Inc. | Full contour breast implant |
US11903816B2 (en) | 2018-02-09 | 2024-02-20 | Tepha, Inc. | Full contour breast implant |
USD1040347S1 (en) | 2018-07-03 | 2024-08-27 | Tepha, Inc. | Three dimensional mastopexy implant |
US11672648B2 (en) | 2018-07-25 | 2023-06-13 | Establishment Labs S.A. | Implants with symmetric shape |
US11779455B2 (en) * | 2018-10-02 | 2023-10-10 | Tepha, Inc. | Medical devices to limit movement of breast implants |
US20200100892A1 (en) * | 2018-10-02 | 2020-04-02 | Tepha, Inc. | Medical devices to limit movement of breast implants |
US11766321B2 (en) | 2019-11-25 | 2023-09-26 | Tepha, Inc. | Breast implant wraps to limit movement of breast implants and related methods |
US11737500B2 (en) * | 2021-08-27 | 2023-08-29 | Cinmar, Llc | Enhancers for use with garments |
US20230065905A1 (en) * | 2021-08-27 | 2023-03-02 | Cinmar, Llc | Enhancers for use with garments |
USD1027375S1 (en) | 2021-08-27 | 2024-05-21 | Cinmar, Llc | Breast tissue enhancer |
SE2230442A1 (en) * | 2022-12-23 | 2024-06-24 | Fascia Innovation Sweden Ab | A human breast implant |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3366975A (en) | Compound prosthesis | |
US3189921A (en) | Compound prosthesis | |
US3683424A (en) | Surgically implantable compound breast prosthesis | |
US3559214A (en) | Compound prosthesis | |
US6277150B1 (en) | Facial implant having one porous surface | |
US3879767A (en) | Prosthesis for articulating body structures | |
US3902198A (en) | Method of replacing a body part with expanded porous polytetrafluoroethylene | |
US6605116B2 (en) | Reinforced radius mammary prostheses and soft tissue expanders | |
US6146418A (en) | Body implant and method of implanting | |
US4531244A (en) | Mammary prosthesis with multiple flow spaces | |
US4960425A (en) | Textured surface frosthesis implants | |
US5480430A (en) | Shape-retaining shell for a fluid filled prosthesis | |
US3849805A (en) | Bone induction in an alloplastic tray | |
JP4436045B2 (en) | Inflatable device and method for reducing bone and spinal injury | |
US4019499A (en) | Compression implant for urinary incontinence | |
EP1592365B1 (en) | Solid implant | |
US3665520A (en) | Surgically implantable breast prosthesis | |
CA2785870C (en) | Breast implants having drug-eluting reservoirs and methods therefor | |
JP3317500B2 (en) | Establishing device for stable living body pocket | |
US20120165934A1 (en) | Collapsible, form-stable, fillable breast prosthesis | |
US20040148024A1 (en) | Soft tissue implant | |
ES2213756T3 (en) | PROCEDURE FOR PREPARATION OF A POROUS MATERIAL DEVICE. | |
US5578085A (en) | Balloon prosthesis for the lung and methods of making and using same | |
JP2016516470A (en) | Angular rings and bonding foils used with balloons for fixation and dynamic stabilization | |
KR20220079816A (en) | Container device for breast implants for reconstructive breast surgery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AMERICAN HOSPITAL SUPPLY CORPORATION; ONE AMERICAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:AMERICAN HEYER- SCHULTE CORPORATION;REEL/FRAME:004099/0695 Effective date: 19830121 |
|
AS | Assignment |
Owner name: MENTOR CORPORATION Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:AMERICAN HOSPITAL SUPPLY CORPORATION AN IL CORP;REEL/FRAME:004281/0957 Effective date: 19840330 |
|
AS | Assignment |
Owner name: AMERICAN HEYER-SCHULTE CORPORATION Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:HEYER-SCHULTE CORPORATION;REEL/FRAME:004245/0660 Effective date: 19800623 |